The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1962, 89: 307-313.
Copyright © 1962 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lancefield, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lancefield, R. C.

Current Knowledge of Type-Specific M Antigens of Group A Streptococci1

Rebecca C. Lancefield

From The Rockefeller Institute, New York, New York

Abstract

It is established that M protein is the cellular component of group A streptococci responsible for the production of type-specific antibodies, which are the basis of type-specific immunity in man. Strains freshly isolated from acute infections, so far as is known at present, always contain M antigen.

Although many cultures containing M protein are avirulent for mice, all highly mouse-virulent group A strains contain M antigen. The amount of M protein in some cultures can be increased by serial mouse passage, and the virulence of such strains is usually increased at the same time. It is possible that the hyaluronic acid capsule in addition to M protein may be a factor in virulence, but its importance has not been clearly defined. M protein probably enhances virulence by impeding phagocytosis, and the capsule may contribute to virulence by a mechanism not yet fully elucidated.

So far no completely purified preparations of M protein have been obtained, but progress in this direction is being made. Once this is achieved, it may be possible to define the properties of this important antigen more accurately.

Footnotes

1 Presidential Address to the American Association of Immunologists, April 16, 1962.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Budzik, L. A. Marraffini, P. Souda, J. P. Whitelegge, K. F. Faull, and O. Schneewind
Amide bonds assemble pili on the surface of bacilli
PNAS, July 22, 2008; 105(29): 10215 - 10220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Dinkla, D. P. Nitsche-Schmitz, V. Barroso, S. Reissmann, H. M. Johansson, I.-M. Frick, M. Rohde, and G. S. Chhatwal
Identification of a Streptococcal Octapeptide Motif Involved in Acute Rheumatic Fever
J. Biol. Chem., June 29, 2007; 282(26): 18686 - 18693.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Clements, D. Tull, A. W. Jenney, J. L. Farn, S.-H. Kim, R. E. Bishop, J. B. McPhee, R. E. W. Hancock, E. L. Hartland, M. J. Pearse, et al.
Secondary Acylation of Klebsiella pneumoniae Lipopolysaccharide Contributes to Sensitivity to Antibacterial Peptides
J. Biol. Chem., May 25, 2007; 282(21): 15569 - 15577.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Neal, B. Beall, K. Ekelund, B. Henriques-Normark, A. Jasir, D. Johnson, E. Kaplan, M. Lovgren, R. R. Reinert, Members of the Strep-EURO Study Group and Internat, et al.
International Quality Assurance Study for Characterization of Streptococcus pyogenes
J. Clin. Microbiol., April 1, 2007; 45(4): 1175 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
T. Siljander, M. Toropainen, A. Muotiala, N. P. Hoe, J. M. Musser, and J. Vuopio-Varkila
emm typing of invasive T28 group A streptococci, 1995-2004, Finland.
J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1701 - 1706.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. K. Stranger-Jones, T. Bae, and O. Schneewind
Vaccine assembly from surface proteins of Staphylococcus aureus
PNAS, November 7, 2006; 103(45): 16942 - 16947.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. L. Kotloff, M. Corretti, K. Palmer, J. D. Campbell, M. A. Reddish, M. C. Hu, S. S. Wasserman, and J. B. Dale
Safety and Immunogenicity of a Recombinant Multivalent Group A Streptococcal Vaccine in Healthy Adults: Phase 1 Trial
JAMA, August 11, 2004; 292(6): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
M. E. Pichichero
Explanations and Therapies for Penicillin Failure in Streptococcal Pharyngitis
Clinical Pediatrics, November 1, 1992; 31(11): 642 - 649.
[Abstract] [PDF]


Home page
ScienceHome page
V. Fischetti, W. Hodges, and D. Hruby
Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant
Science, June 23, 1989; 244(4911): 1487 - 1490.
[Abstract] [PDF]


Home page
ScienceHome page
J. Spanier, S. Jones, and P Cleary
Small DNA deletions creating avirulence in Streptococcus pyogenes
Science, August 31, 1984; 225(4665): 935 - 938.
[Abstract] [PDF]


Home page
ScienceHome page
Scott JR and V. Fischetti
Expression of streptococcal M protein in Escherichia coli
Science, August 19, 1983; 221(4612): 758 - 760.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1962 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1962 by The American Association of Immunologists, Inc. All rights reserved.